Next Generation Sequencing (NGS) Sample Preparation - Global Strategic Business Report

The global market for Next Generation Sequencing (NGS) Sample Preparation was estimated at US$3.3 Billion in 2023 and is projected to reach US$10.5 Billion by 2030, growing at a CAGR of 18.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Next Generation Sequencing (NGS) Sample Preparation Market - Key Trends and Drivers Summarized

How Is Next Generation Sequencing (NGS) Sample Preparation Evolving Genomics?

Next Generation Sequencing (NGS) Sample Preparation is a crucial step in the genomic sequencing process, enabling the accurate analysis of DNA and RNA for research, clinical diagnostics, and personalized medicine. This process involves DNA/RNA extraction, library preparation, and target enrichment, all of which are critical for obtaining high-quality sequencing results. NGS sample preparation has advanced significantly with innovations such as automation, multiplexing, and single-cell analysis, allowing for faster and more precise genomic analysis. As genomics becomes integral to understanding diseases, drug development, and population genetics, efficient sample preparation is essential for unlocking the full potential of NGS technologies.

What Are the Key Segments in the NGS Sample Preparation Market?

Key products include reagents, kits, instruments, and consumables, with reagents and kits dominating the market due to their frequent use in library preparation and target enrichment. In terms of workflow, the market covers DNA extraction, library preparation, and target enrichment, with library preparation being the largest segment. Major end-users include academic research institutions, hospitals, pharmaceutical companies, and clinical laboratories, all of which use NGS sample preparation to conduct genomic studies, develop personalized therapies, and diagnose genetic disorders.

How Is NGS Sample Preparation Being Adopted Across Sectors?

Academic research institutions are the largest users of NGS sample preparation, utilizing it for genomic research, gene expression studies, and biomarker discovery. Hospitals and clinical laboratories leverage NGS sample preparation for diagnosing genetic disorders, detecting infectious diseases, and guiding personalized treatment plans. Pharmaceutical companies use it to identify genetic targets, develop new drugs, and conduct clinical trials, where genomic data plays a critical role in drug efficacy analysis. The growing interest in population genetics and precision medicine is further driving the adoption of NGS sample preparation in government-funded genomic projects and biobanks, which require large-scale sequencing for genetic analysis.

What Factors Are Driving the Growth in the NGS Sample Preparation Market?

The growth in the Next Generation Sequencing Sample Preparation market is driven by several factors, including the increasing demand for genomics in disease research, personalized medicine, and drug development. Technological advancements in automation and multiplexing have improved the efficiency and accuracy of sample preparation, enhancing the overall speed of NGS workflows. The rise of precision medicine, which relies heavily on genetic insights, has further fueled the need for advanced sample preparation techniques. Government initiatives and funding for genomic research, coupled with the expansion of clinical genomics, are contributing to market growth. The increasing use of NGS in cancer diagnostics, rare disease detection, and infectious disease monitoring is also driving the demand for efficient sample preparation solutions.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Reagents & Consumables segment, which is expected to reach US$6.9 Billion by 2030 with a CAGR of a 19.7%. The Workstations segment is also set to grow at 15.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $905.4 Million in 2023, and China, forecasted to grow at an impressive 17.0% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Next Generation Sequencing (NGS) Sample Preparation Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Next Generation Sequencing (NGS) Sample Preparation Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Next Generation Sequencing (NGS) Sample Preparation Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players in the Global Next Generation Sequencing (NGS) Sample Preparation Market such as Agilent Technologies, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Berry Genomics, BGI and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 32 companies featured in this Global Next Generation Sequencing (NGS) Sample Preparation market report include:

• Agilent Technologies
• Beckman Coulter (A Subsidiary of Danaher)
• Becton, Dickinson and Company
• Berry Genomics
• BGI
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• Macrogen
• New England Biolabs, Inc.
• Novo Gene
• Nugen Technologies, Inc.
• Oxford Gene Technology
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• Perkinelmer, Inc.
• Qiagen N.V
• Raindance Technologies, Inc.
• Swift Biosciences Inc.
• Thermo Fisher
• WuXi AppTec